{"id":"https://openalex.org/W2000820979","doi":"https://doi.org/10.1016/j.nbd.2009.07.033","title":"Assessment of the blood\u2013brain barrier in CNS drug discovery","display_name":"Assessment of the blood\u2013brain barrier in CNS drug discovery","publication_year":2009,"publication_date":"2009-08-06","ids":{"openalex":"https://openalex.org/W2000820979","doi":"https://doi.org/10.1016/j.nbd.2009.07.033","mag":"2000820979","pmid":"https://pubmed.ncbi.nlm.nih.gov/19664709"},"language":"en","primary_location":{"id":"doi:10.1016/j.nbd.2009.07.033","doi":"https://doi.org/10.1016/j.nbd.2009.07.033","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.nbd.2009.07.033","pdf_url":null,"source":{"id":"https://openalex.org/S35878148","display_name":"Neurobiology of Disease","issn_l":"0969-9961","issn":["0969-9961","1095-953X"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurobiology of Disease","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doaj.org/article/01b1d732c2bd4e22b73975dee2b5bef5","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5011157656","display_name":"Phil Jeffrey","orcid":"https://orcid.org/0000-0003-4131-7218","observed_orcids":["https://orcid.org/0000-0003-4131-7218"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]},{"id":"https://openalex.org/I4405268060","display_name":"GlaxoSmithKline Research & Development Limited (United Kingdom)","ror":"https://ror.org/05mayyh83","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405268060"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Phil Jeffrey","raw_affiliation_strings":["Immunoinflammation Centre of Excellence for Drug Discovery, GlaxoSmithKline R&D, Gunnels Wood Road, Stevenage, SG1 2NY, UK. phillip.x.jeffrey@gsk.com","Immunoinflammation Centre of Excellence for Drug Discovery, GlaxoSmithKline R&D, Gunnels Wood Road, Stevenage, SG1 2NY, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunoinflammation Centre of Excellence for Drug Discovery, GlaxoSmithKline R&D, Gunnels Wood Road, Stevenage, SG1 2NY, UK. phillip.x.jeffrey@gsk.com","institution_ids":["https://openalex.org/I188950975","https://openalex.org/I4405268060"]},{"raw_affiliation_string":"Immunoinflammation Centre of Excellence for Drug Discovery, GlaxoSmithKline R&D, Gunnels Wood Road, Stevenage, SG1 2NY, UK","institution_ids":["https://openalex.org/I188950975","https://openalex.org/I4405268060"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108716684","display_name":"Scott G. Summerfield","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Scott Summerfield","raw_affiliation_strings":["Preclinical Development, Drug Metabolism and Pharmacokinetics, GlaxoSmithKline R&D, Park Road, Ware, SG12 0DP, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Preclinical Development, Drug Metabolism and Pharmacokinetics, GlaxoSmithKline R&D, Park Road, Ware, SG12 0DP, UK","institution_ids":["https://openalex.org/I188950975"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5011157656"],"corresponding_institution_ids":["https://openalex.org/I188950975","https://openalex.org/I4405268060"],"apc_list":{"value":4180,"currency":"USD","value_usd":4180},"apc_paid":null,"fwci":0.769,"has_fulltext":false,"cited_by_count":130,"citation_normalized_percentile":{"value":0.61570248,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":100},"biblio":{"volume":"37","issue":"1","first_page":"33","last_page":"37"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11872","display_name":"Barrier Structure and Function Studies","score":0.9775000214576721,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11872","display_name":"Barrier Structure and Function Studies","score":0.9775000214576721,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.02019999921321869,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/blood-brain-barrier","display_name":"blood-brain barrier","score":0.9929999709129333},{"id":"https://openalex.org/keywords/cns-drug-discovery","display_name":"CNS drug discovery","score":0.890999972820282},{"id":"https://openalex.org/keywords/brain-to-blood-ratio","display_name":"brain-to-blood ratio","score":0.7300000190734863},{"id":"https://openalex.org/keywords/drug-permeability","display_name":"drug permeability","score":0.640999972820282},{"id":"https://openalex.org/keywords/active-efflux","display_name":"active efflux","score":0.8059999942779541},{"id":"https://openalex.org/keywords/drug-partitioning","display_name":"drug partitioning","score":0.6060000061988831},{"id":"https://openalex.org/keywords/brain-tissue-distribution","display_name":"brain tissue distribution","score":0.7519999742507935},{"id":"https://openalex.org/keywords/free-drug-concentration","display_name":"free drug concentration","score":0.9229999780654907},{"id":"https://openalex.org/keywords/physicochemical-properties","display_name":"physicochemical properties","score":0.7549999952316284}],"concepts":[{"id":"https://openalex.org/C2778402981","wikidata":"https://www.wikidata.org/wiki/Q221694","display_name":"Blood\u2013brain barrier","level":3,"score":0.7553797960281372},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.6530486941337585},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.537265419960022},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.49808382987976074},{"id":"https://openalex.org/C80107235","wikidata":"https://www.wikidata.org/wiki/Q7162625","display_name":"Penetration (warfare)","level":2,"score":0.4200066030025482},{"id":"https://openalex.org/C200082930","wikidata":"https://www.wikidata.org/wiki/Q22327148","display_name":"Efflux","level":2,"score":0.41419756412506104},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.409176766872406},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.352370023727417},{"id":"https://openalex.org/C529278444","wikidata":"https://www.wikidata.org/wiki/Q47273","display_name":"Central nervous system","level":2,"score":0.3257869482040405},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.298961877822876},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.2198258340358734},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.06888175010681152},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C42475967","wikidata":"https://www.wikidata.org/wiki/Q194292","display_name":"Operations research","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001812","descriptor_name":"Blood-Brain Barrier","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D001812","descriptor_name":"Blood-Brain Barrier","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D001812","descriptor_name":"Blood-Brain Barrier","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D001927","descriptor_name":"Brain Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001927","descriptor_name":"Brain Diseases","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D002199","descriptor_name":"Capillary Permeability","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002199","descriptor_name":"Capillary Permeability","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013118","descriptor_name":"Spinal Cord Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D013118","descriptor_name":"Spinal Cord Diseases","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D055808","descriptor_name":"Drug Discovery","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1016/j.nbd.2009.07.033","doi":"https://doi.org/10.1016/j.nbd.2009.07.033","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.nbd.2009.07.033","pdf_url":null,"source":{"id":"https://openalex.org/S35878148","display_name":"Neurobiology of Disease","issn_l":"0969-9961","issn":["0969-9961","1095-953X"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurobiology of Disease","raw_type":"journal-article"},{"id":"pmid:19664709","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19664709","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurobiology of disease","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:01b1d732c2bd4e22b73975dee2b5bef5","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/01b1d732c2bd4e22b73975dee2b5bef5","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Neurobiology of Disease, Vol 37, Iss 1, Pp 33-37 (2010)","raw_type":"article"}],"best_oa_location":{"id":"pmh:oai:doaj.org/article:01b1d732c2bd4e22b73975dee2b5bef5","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/01b1d732c2bd4e22b73975dee2b5bef5","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Neurobiology of Disease, Vol 37, Iss 1, Pp 33-37 (2010)","raw_type":"article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":47,"referenced_works":["https://openalex.org/W204521712","https://openalex.org/W1568560565","https://openalex.org/W1964039613","https://openalex.org/W1967546408","https://openalex.org/W1970263371","https://openalex.org/W1973091091","https://openalex.org/W1973613551","https://openalex.org/W1980895154","https://openalex.org/W1988896100","https://openalex.org/W1990250882","https://openalex.org/W1992758695","https://openalex.org/W1995735458","https://openalex.org/W2000285669","https://openalex.org/W2005072188","https://openalex.org/W2009979602","https://openalex.org/W2015541518","https://openalex.org/W2039297169","https://openalex.org/W2045529054","https://openalex.org/W2050502325","https://openalex.org/W2053091943","https://openalex.org/W2058780134","https://openalex.org/W2063255933","https://openalex.org/W2066941852","https://openalex.org/W2071052390","https://openalex.org/W2077216169","https://openalex.org/W2082959774","https://openalex.org/W2088206004","https://openalex.org/W2108141803","https://openalex.org/W2112893277","https://openalex.org/W2115922181","https://openalex.org/W2117024164","https://openalex.org/W2125136428","https://openalex.org/W2125865712","https://openalex.org/W2128527026","https://openalex.org/W2129200919","https://openalex.org/W2132134960","https://openalex.org/W2134023145","https://openalex.org/W2134756034","https://openalex.org/W2137053703","https://openalex.org/W2141108781","https://openalex.org/W2145978043","https://openalex.org/W2148992136","https://openalex.org/W2156014915","https://openalex.org/W2158900181","https://openalex.org/W2162139696","https://openalex.org/W2163209521","https://openalex.org/W2950083701"],"related_works":["https://openalex.org/W2332832753","https://openalex.org/W2000285669","https://openalex.org/W2030028063","https://openalex.org/W2119841462","https://openalex.org/W6997134081","https://openalex.org/W1519025784","https://openalex.org/W1953282970","https://openalex.org/W4377223843","https://openalex.org/W2005447377","https://openalex.org/W6980269212"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":12},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":10},{"year":2021,"cited_by_count":10},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":10},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":17},{"year":2012,"cited_by_count":12}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}